Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Top Cited Papers
- 1 July 2007
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 370 (9584), 319-328
- https://doi.org/10.1016/s0140-6736(07)61162-3
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and WalesAddiction, 2007
- Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidenceBMJ, 2006
- An Experimental Study of Catechol-O-Methyltransferase Val158Met Moderation of Δ-9-Tetrahydrocannabinol-Induced Effects on Psychosis and CognitionNeuropsychopharmacology, 2006
- Incidence and Outcomes of Mental Disorders in a Regional Population: The Northern Rivers Mental Health StudyAustralian & New Zealand Journal of Psychiatry, 2006
- The Environment and Schizophrenia: The Role of Cannabis UseSchizophrenia Bulletin, 2005
- THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGYAlcohol and Alcoholism, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Effects of adolescent drug use on adult mental health: A prospective study of a community sample.Experimental and Clinical Psychopharmacology, 1993
- Ventral tegmental microinjection of Δ9-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredientBrain Research, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986